COVID-19 reinfection in the presence of neutralizing antibodies

Author:

Zhang Ju12,Ding Nan12,Ren Lili34,Song Rui1,Chen Danying12,Zhao Xuesen12,Chen Budong1,Han Junyan12,Li Jiarui12,Song Yangzi12,Di Lin5,Han Kai12,Yu Fengting1,Xie Ruming1,Chen Zhihai1,Xie Wen1,Liu Jingyuan1,Cen Shan6,Bi Yuhai78,Wu Angela R9ORCID,Zhang Fujie1,Chen Chen12,Zeng Hui12

Affiliation:

1. Beijing Ditan Hospital, Capital Medical University, China

2. Beijing Key Laboratory of Emerging Infectious Diseases, China

3. NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, China

4. Key Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, China

5. Beijing Advanced Innovation Center for Genomics, Biomedical Pioneering Innovation Center, Peking University, China

6. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical School, China

7. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, China

8. University of Chinese Academy of Sciences, China

9. Division of Life Science and Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology, China

Abstract

After a short recovery period, COVID-19 reinfections could occur in convalescent patients, even those with measurable levels of neutralizing antibodies. Effective vaccinations and protective public health measures are recommended for the convalescent COVID-19 patients.

Funder

National Key Research and Development Program

Beijing Municipal Science and Technology Commission

Publisher

Oxford University Press (OUP)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3